Reducing West Nile Virus risk through vector management. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Mostashari F, Bunning ML, Kitsutani PT, et al. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. Montgomery SP, Brown JA, Kuehnert M, et al. Evaluation of efficacy and human health risk of aerial ultra-low volume applications of pyrethrins and piperonyl butoxide for adult mosquito management in response to West Nile Virus activity in Sacramento County, California. Macedo PA, Schleier III JJ, Reed M, Kelley K, Goodman G, Brown D, Peterson RKD. Lindsey NP, Hayes EB, Staples JE, Fischer M. Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Lindsey NP, Sejvar JJ, Bode AV, Pape WJ, Campbell GL. ![]() Medical risk factors for severe West Nile virus disease, United States, 2008-2010. Lindsey NP, Staples JE, Lehman JA, Fischer M. State health department perceived utility of and satisfaction with ArboNET, the U.S. Lindsey NP, Brown JA, Kightlinger L, et al. Laboratory testing practices for West Nile virus in the United States. Janusz KB, Lehman JA, Panella AJ, Fischer M, Staples JE. Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients. Spatio -temporal impacts of aerial adul ticide applications on populations of West Nile virus vector mosquitoes. Virology, pathology, and clinical manifestations of West Nile Virus disease. Epidemiology and transmission dynamics of West Nile virus disease. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. Gibney KB, Lanciotti RS, Sejvar JJ, et al. Modifiable risk factors for West Nile virus infection during an outbreak – Arizona, 2010. Detection of yellow fever immunoglobulin M antibodies at 3-4 years following yellow fever vaccination. Gibney KB, Edupuganti S, Panella AJ, et al. Progress on the development of therapeutics against West Nile virus. Evaluation for West Nile virus (WNV) RNA in urine of patients within 5 months of WNV infection. Surveillance for West Nile Virus Disease - United States, 2009–2018 Selected Publications in Peer-Reviewed Literatureīaty SA, Gibney KB, Staples JE, et al. West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases - United States, 2018 West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases - United States, 2019 ![]() West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases - United States, 2020 West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2021 West Nile Virus in the United States: Guidelines for Surveillance, Prevention, and Control Morbidity and Mortality Weekly Reports (MMWR) Guidelines for Surveillance, Prevention, and Control
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |